DRUGS · FINISHED DOSAGE

Pharmaceutical formulation FDA Compliance Service

For finished pharmaceutical manufacturers, brand parties and label duty-bearers, support is provided on the application of listing routes, facility registration, NDC Labler Code application, NDC code, Drug Listing, OTC monographs, labels and annual maintenance.

START HERE

Let's sort out the product, then choose the service.

  1. 01

    Check the drug trail first.

    Provide composition, agent type, route of delivery, use and existing declared status.

  2. 02

    Clarifying the roles of business and products

    (c) To distinguish between manufacturing facilities, labelers and those responsible for associated information.

  3. 03

    Documentation and maintenance requirements

    Identify registration, listing, technical papers and information changes that need to be addressed.

SERVICE DIRECTORY

Selection of specific services according to demand

The use of products, business activities and information is identified before the range of services is determined. The relevant services can be combined.

01

Formulation classification and course of application

(b) Aggregation of applicable paths with product facts; The specific scope of support for registered declarations, such as NDA, ANDA, is confirmed separately.

02

Facilities registration, listing and liaison

The responsibilities of manufacturing facilities, brand parties, Labeler and U.S. agents are judged separately.

NDC Labeler Code Application

Checking the subject of the manufacturer’s or owner’s brand dealer’s application to assist in the preparation of Labeler Code requests, post-allocation confirmations and information changes; Process as separate from facility registration, complete NDC and product listing.

View service details

D.U.N.S.

Assist in searching and checking D-U-N-S records of pharmaceutical facilities or related subjects, and press D&B Current process to sort requests or correct information; Reconnected with the registration and listing information of the FDA pharmaceutical facility. D-U-N-S by D-D-E-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-S-T-S-T-T-T-A-T-T-T-T-T-T-T-A-T-T-T-T-T-T-T-A-T-T-T-A-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-T-&B Management, not FDA approval or registration certificate.

View service details

U.S. agent services

U.S. agent designation, FDA liaison, inspection arrangements for communication and agent information maintenance support are provided to drug facilities outside the country that are legally required to register.

View service details
03

Label, electronic files and annual maintenance

Document support and continuous updating based on identified pathways and information ranges.

Certification of drug labels

Assist in checking label information against content that requires further identification, based on the type of drug, applicable listing route, labeler and product information. Specific requirements vary according to product and route.

View service details

The legal listing path of the product is verified. (a) Complete the registration of the facility, Drug Listing or access to the NDC is not equivalent to FDA approval; The scope of the specific service, test and technical declaration is subject to the project agreement.

ONGOING SUPPORT

Drug projects need to be continuously checked against product life cycle

Discuss record maintenance →
  • To confirm whether relevant registration and listing information needs to be maintained when business activity, facility information, product state or party responsible changes.
  • Re-verification of existing declaration arrangements and applicable requirements in the event of changes in formulations, formulation types, labels or listing paths.
  • DMF documents, authorized references and technical updates should be linked to the application and the project scope identified by both parties.
BEFORE YOU DECIDE

You might care before you choose a pharmaceutical service.

Can finished medicines be sold in the United States when they are registered and listed?

It cannot be judged solely by registration, listing or NDC. The application of listing routes and formulations, labels, quality of production, etc., needs to be confirmed; Products subject to listing should also be checked against the corresponding approval status.

Do brand parties have the same procedures as substitute factories?

It should be judged by their actual activities and regulatory roles. Brands, production facilities, packaging labelling facilities and Labeler may belong to different subjects and cannot replace full responsibility in the supply chain with the same enterprise name.

Is it possible to align the cost of the commitment and the time of completion?

The product path, the integrity of the information and the scope of work need to be checked first, and a distinction made between official FDA costs, testing costs and third-party service costs.

Is it the same thing with Laborer Code, NDC and Drug Listing?

No. Labeler Code, used to identify counterpart drug marketing enterprises, is part of the NDC; The complete NDC also includes product and packaging information, and Drug Listing submits specific drug listings to FDA. (b) The Label Code process needs to be completed before the initial listing or retention of the NDC; Obtaining the code does not amount to a drug being approved.

RELATED READING

Explore related rules and projects

Browse related guidance →
DEFINE YOUR NEXT STEP

Provide products and current information to confirm service application.

The content, formulation type, route of delivery, use, labelling and the existing listing basis are provided first, and the specific service content and costs are based on the project scope identified by both parties.